Hypertension in African Americans with heart failure: progression from hypertrophy to dilatation; perhaps not

Pallavi Solanki1, Ramzan M Zakir, Rajiv J Patel

  • 1Division of Cardiovascular Diseases, Rutgers, The State University of New Jersey-New Jersey Medical School, 185 S. Orange Avenue, Newark, NJ, 07103, USA.

Insights

Long-standing hypertension (HTN) may not always cause left ventricular (LV) dilatation and systolic failure. In African American patients with heart failure (HF), genetics and gender appear to influence the response to HTN.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Hypertension Research

Background:

  • Concentric hypertrophy is a common cardiac adaptation to long-standing hypertension (HTN).
  • The transition of concentric hypertrophy to left ventricular (LV) dilatation and systolic failure is a presumed consequence of HTN.
  • The routine occurrence of this transition in humans remains uncertain.

Purpose of the Study:

  • To investigate the progression of hypertensive heart disease in African American patients.
  • To determine if concentric hypertrophy consistently leads to LV dilatation and systolic failure in the context of HTN.
  • To explore factors influencing individual responses to chronic hypertension.

Main Methods:

  • Retrospective study of African American patients hospitalized for acute decompensated heart failure (HF) with a history of HTN and no obstructive coronary disease.
  • Patients categorized into groups with normal and reduced left ventricular ejection fraction (LVEF).
  • Left ventricular (LV) dimensions and mass were measured using established echocardiographic guidelines and formulas.

Main Results:

  • Patients with normal LVEF HF were older, predominantly female, and had longer HTN duration with higher admission systolic blood pressure.
  • Both groups exhibited elevated LV wall thickness; LV mass was significantly greater in the reduced LVEF HF group.
  • Female gender independently predicted LV wall thickness in the normal LVEF HF group.

Conclusions:

  • The study challenges the traditional view that concentric hypertrophy invariably progresses to LV dilatation and systolic failure in hypertensive patients.
  • Genetic factors and gender significantly influence the cardiac remodeling response to long-standing hypertension.
  • Individual variability in response to HTN warrants further investigation in diverse populations.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
651